The primary role of iron-mediated lipid peroxidation in the differential cytotoxicity caused by two varieties of talc nanoparticles on A549 cells and lipid peroxidation inhibitory effect exerted by ascorbic acid

被引:34
作者
Akhtar, Mohd Javed [1 ]
Kumar, Sudhir [2 ]
Murthy, Ramesh Chandra [3 ]
Ashquin, Mohd [1 ]
Khan, Mohd Imran [1 ]
Patil, Govil [1 ]
Ahmad, Iqbal [1 ]
机构
[1] Indian Inst Toxicol Res, Fibre Toxicol Div, CSIR, Lucknow 226001, Uttar Pradesh, India
[2] Univ Lucknow, Dept Zool, Lucknow 226001, Uttar Pradesh, India
[3] Indian Inst Toxicol Res, Div Analyt Chem, CSIR, Lucknow 226001, Uttar Pradesh, India
关键词
Talc nanoparticles; Cytotoxicity; Lipid peroxidation; Reactive oxygen species; Glutathione; Oxidative stress; Iron contamination; OVARIAN-CANCER RISK; NF-KAPPA-B; ULTRAFINE PARTICLES; OXIDATIVE STRESS; VITAMIN-C; EPITHELIAL-CELLS; NALP3; INFLAMMASOME; LUNG-CARCINOMA; FREE-RADICALS; IN-VIVO;
D O I
10.1016/j.tiv.2010.03.002
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Talc particles, the basic ingredient in different kinds of talc-based cosmetic and pharmaceutical products, pose a health risk to pulmonary and ovarian systems due to domestic and occupational exposures. Two types of talc nanoparticles depending on the source of geographical origin - indigenous- and commercial talc nanoparticles were assessed for their potential in vitro toxicity on A(549) cells; along with indigenous conventionally used microtalc particles. Cell viability, determined through live/dead staining and 3-(4,5-dimethyl thiazol-2-yl)-2.5-diphenyl tetrazolium bromide (MTT) assay, decreased as a function of concentration, origin and size of particles. Both varieties of talc nanoparticles differentially induced lipid peroxidation (LPO), which was correlated with the pattern of lactate dehydrogenase (LDH) leakage, reactive oxygen species (ROS) generation, and glutathione (GSH) depletion. Relatively higher cytotoxicity of indigenous nanotalc could be attributed to its higher content of iron as compared to commercial nanotalc. The known scavenger of ROS, L-ascorbic acid significantly inhibited LPO induction due to talc particles. Data suggest that nanotalc toxicity on A(549) cells was mediated through oxidative stress, wherein role of iron-mediated LPO was much pronounced in differential cytotoxicity. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1139 / 1147
页数:9
相关论文
共 83 条
[41]   The relationship between perineal cosmetic talc usage and ovarian talc particle burden [J].
Heller, DS ;
Westhoff, C ;
Gordon, RE ;
Katz, N .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (05) :1507-1510
[42]  
HENDERSON WJ, 1971, J OBSTET GYN BR COMM, V78, P266
[43]   Reactive oxygen species and protein oxidation in aging: A look back, a look ahead [J].
Hensley, K ;
Floyd, RA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 397 (02) :377-383
[44]   FLUOROMETRIC METHOD FOR DETERMINATION OF OXIDIZED AND REDUCED GLUTATHIONE IN TISSUES [J].
HISSIN, PJ ;
HILF, R .
ANALYTICAL BIOCHEMISTRY, 1976, 74 (01) :214-226
[45]  
HOLLINGER MA, 1990, TOXICOL LETT, V52, P121, DOI 10.1016/0378-4274(90)90145-C
[46]   Research strategies for safety evaluation of nanomaterials, part II: Toxicological and safety evaluation of nanomaterials, current challenges and data needs [J].
Holsapple, MP ;
Farland, WH ;
Landry, TD ;
Monteiro-Riviere, NA ;
Carter, JM ;
Walker, NJ ;
Thomas, KV .
TOXICOLOGICAL SCIENCES, 2005, 88 (01) :12-17
[47]   Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation [J].
Huang, M ;
Khor, E ;
Lim, LY .
PHARMACEUTICAL RESEARCH, 2004, 21 (02) :344-353
[48]   Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene [J].
Isakovic, A ;
Markovic, Z ;
Todorovic-Markovic, B ;
Nikolic, N ;
Vranjes-Djuric, S ;
Mirkovic, M ;
Dramicanin, M ;
Harhaji, L ;
Raicevic, N ;
Nikolic, Z ;
Trajkovic, V .
TOXICOLOGICAL SCIENCES, 2006, 91 (01) :173-183
[49]   Smaller is not always better: nanotechnology yields nanotoxicology [J].
Kipen, HM ;
Laskin, DL .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 289 (05) :L696-L697
[50]  
KRUG HF, 1991, MOL PHARMACOL, V39, P511